Article Information
History
- July 11, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Ryan Ramanujam, PhD1,2,
- Feng Zhu3,
- Katharina Fink, MD1,4,6,
- Virginija Danylaitė Karrenbauer, MD1,4,
- Johannes Lorscheider, MD7,
- Pascal Benkert, PhD8,
- Elaine Kingwell3,
- Helen Tremlett3,
- Jan Hillert, MD1,4,
- Ali Manouchehrinia, PhD1,5,*,
- The BeAMS Study group
- 1Department of Clinical Neuroscience, Karolinska Institutet, Widerströmska huset Tomtebodavägen 18A, floor 5, 171 77, Stockholm, Sweden
- 2Department of Mathematics, KTH - Royal Institute of Technology, 100 44 Stockholm, Sweden
- 3Faculty of Medicine (Neurology), UBC Hospital, and Djavad Mowafaghian Centre for Brain Health, University of British Columbia, 2211 Wesbrook Mall, Vancouver, BC V6T 2B5, Canada
- 4Neuro Theme, Karolinska University Hospital, 14186 Stockholm
- 5The Karolinska Neuroimmunology & Multiple Sclerosis Centre, Karolinska Institutet; Centre for Molecular Medicine (CMM) L8:05 | SE-171 76 Stockholm, Sweden
- 6Academic Specialist Center, Multiple Sclerosis Centre, Solnavägen 1E, 11365 Stockholm
- 7Neurologic Clinic and Policlinic, Departments of Medicine and Clinical Research, University Hospital Basel, University of Basel, CH-4031 Basel, Switzerland
- 8Clinical Trial Unit, Department of Clinical Research, University Hospital Basel, CH-4031 Basel, Switzerland
- ↵*Corresponding author:
Dr Ali Manouchehrinia, Email:
ali.manouchehrinia{at}ki.se, Address:
Karolinska Institutet, Centre for Molecular Medicine (CMM) L8:05, SE-171 76 Stockholm, Sweden, Tel:
+46 (0) 73 87 02423
Posted July 11, 2020.
